Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
21.4 SEK | -1.61% | +4.39% | +38.42% |
May. 08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.42% | 69.83M | |
+9.28% | 8.74B | |
-14.24% | 4.94B | |
+49.95% | 4.7B | |
+5.96% | 3.98B | |
-23.57% | 2.28B | |
+13.92% | 2.28B | |
+17.77% | 2.14B | |
-32.28% | 2.12B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Orexo Hires New Chief Medical Officer